Articoli con mandati relativi all'accesso pubblico - Richard A. FlavellUlteriori informazioni
Non disponibili pubblicamente: 25
Controlla
CD4 T-cell differentiation and inflammatory bowel disease
LA Zenewicz, A Antov, RA Flavell
Trends in molecular medicine 15 (5), 199-207, 2009
Mandati: Howard Hughes Medical Institute
Controlla
NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity
M Divangahi, S Mostowy, F Coulombe, R Kozak, L Guillot, F Veyrier, ...
The Journal of immunology 181 (10), 7157-7165, 2008
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
Controlla
The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer.
J Geginat, P Larghi, M Paroni, G Nizzoli, A Penatti, M Pagani, N Gagliani, ...
Cytokine & growth factor reviews 30, 87-93, 2016
Mandati: Fondazione Cariplo, Governo Italiano
Controlla
A pathogenic role for T cell–derived IL-22BP in inflammatory bowel disease
P Pelczar, M Witkowski, LG Perez, J Kempski, AG Hammel, L Brockmann, ...
Science 354 (6310), 358-362, 2016
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, German …
Controlla
Inflammasomes and metabolic disease
J Henao-Mejia, E Elinav, CA Thaiss, RA Flavell
Annual review of physiology 76 (1), 57-78, 2014
Mandati: Howard Hughes Medical Institute
Controlla
Immunity, microbiota and kidney disease
F Knauf, JR Brewer, RA Flavell
Nature Reviews Nephrology 15 (5), 263-274, 2019
Mandati: Howard Hughes Medical Institute, German Research Foundation
Controlla
Teplizumab induces human gut-tropic regulatory cells in humanized mice and patients
F Waldron-Lynch, O Henegariu, S Deng, P Preston-Hurlburt, J Tooley, ...
Science Translational Medicine 4 (118), 118ra12-118ra12, 2012
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Controlla
The intestinal microbiota in chronic liver disease
J Henao-Mejia, E Elinav, CA Thaiss, RA Flavell
Advances in immunology 117, 73-97, 2013
Mandati: Howard Hughes Medical Institute
Controlla
Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapy
ER Steenblock, SH Wrzesinski, RA Flavell, TM Fahmy
Expert opinion on biological therapy 9 (4), 451-464, 2009
Mandati: Howard Hughes Medical Institute
Controlla
Transforming growth factor-β: recent advances on its role in immune tolerance
MA Kriegel, MO Li, S Sanjabi, YY Wan, RA Flavell
Current rheumatology reports 8 (2), 138-144, 2006
Mandati: German Research Foundation
Controlla
Myosin I: from yeast to human
SV Kim, RA Flavell
Cellular and Molecular Life Sciences 65, 2128-2137, 2008
Mandati: Howard Hughes Medical Institute
Controlla
Roles of Cav channels and AHNAK1 in T cells: the beauty and the beast
D Matza, RA Flavell
Immunological reviews 231 (1), 257-264, 2009
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
Controlla
A protective function of IL-22BP in ischemia reperfusion and acetaminophen-induced liver injury
D Kleinschmidt, AD Giannou, HM McGee, J Kempski, B Steglich, ...
The Journal of Immunology 199 (12), 4078-4090, 2017
Mandati: German Research Foundation
Controlla
Deprivation of MKK7 in cardiomyocytes provokes heart failure in mice when exposed to pressure overload
W Liu, M Zi, H Chi, J Jin, S Prehar, L Neyses, EJ Cartwright, RA Flavell, ...
Journal of molecular and cellular cardiology 50 (4), 702-711, 2011
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, British …
Controlla
Costimulatory strength influences the differential effects of transforming growth factor β1 for the generation of CD8+ regulatory T cells
TM Fan, DM Kranz, RA Flavell, EJ Roy
Molecular immunology 45 (10), 2937-2950, 2008
Mandati: US National Institutes of Health
Controlla
Colitis promotes a pathological condition of the liver in the absence of Foxp3+ regulatory T cells
F Mathies, N Steffens, D Kleinschmidt, F Stuhlmann, FJ Huber, U Roy, ...
The Journal of Immunology 201 (12), 3558-3568, 2018
Mandati: German Research Foundation
Controlla
Role of OCT-1 and partner proteins in T cell differentiation
SS Hwang, LK Kim, GR Lee, RA Flavell
Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1859 (6), 825-831, 2016
Mandati: Howard Hughes Medical Institute
Controlla
Dendritic cell differentiation induced by a self-peptide derived from apolipoprotein E
TA Stephens, E Nikoopour, BJ Rider, M Leon-Ponte, TA Chau, ...
The Journal of Immunology 181 (10), 6859-6871, 2008
Mandati: Howard Hughes Medical Institute, Canadian Institutes of Health Research
Controlla
Role of IL-10 Receptor Signaling in the Function of CD4+ T-Regulatory Type 1 cells: T-Cell Therapy in Patients with Inflammatory Bowel Disease
S Soukou, L Brockmann, T Bedke, N Gagliani, RA Flavell, S Huber
Critical reviews™ in immunology 38 (5), 2018
Mandati: Howard Hughes Medical Institute
Controlla
Essential roles for Cavβ2 and Cav1 channels in thymocyte development and T cell homeostasis
A Jha, AK Singh, P Weissgerber, M Freichel, V Flockerzi, RA Flavell, ...
Science signaling 8 (399), ra103-ra103, 2015
Mandati: Howard Hughes Medical Institute, German Research Foundation
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software